Stephen G. Walsh

Array ( [id] => 2977272 [patent_doc_number] => 05225543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-06 [patent_title] => 'Receptors method for purification of G protein-linked' [patent_app_type] => 1 [patent_app_number] => 7/677003 [patent_app_country] => US [patent_app_date] => 1991-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 12505 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/225/05225543.pdf [firstpage_image] =>[orig_patent_app_number] => 677003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2952069 [patent_doc_number] => 05262528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-16 [patent_title] => 'cDNA probe differentiating normal and cancer tissues' [patent_app_type] => 1 [patent_app_number] => 7/662198 [patent_app_country] => US [patent_app_date] => 1991-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2721 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/262/05262528.pdf [firstpage_image] =>[orig_patent_app_number] => 662198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3064091 [patent_doc_number] => 05352603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Highly alkaline proteases' [patent_app_type] => 1 [patent_app_number] => 7/661378 [patent_app_country] => US [patent_app_date] => 1991-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 15106 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352603.pdf [firstpage_image] =>[orig_patent_app_number] => 661378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2919288 [patent_doc_number] => 05234905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Soluble CD4 molecules modified to prolong circulating half-life' [patent_app_type] => 1 [patent_app_number] => 7/669849 [patent_app_country] => US [patent_app_date] => 1991-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7171 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/234/05234905.pdf [firstpage_image] =>[orig_patent_app_number] => 669849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2934141 [patent_doc_number] => 05219990 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Papillomavirus E2 trans-activation repressors' [patent_app_type] => 1 [patent_app_number] => 7/646998 [patent_app_country] => US [patent_app_date] => 1991-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 17291 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219990.pdf [firstpage_image] =>[orig_patent_app_number] => 646998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2933835 [patent_doc_number] => 05229367 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-20 [patent_title] => 'Antiinflammatory peptide derived from human lipocortin V' [patent_app_type] => 1 [patent_app_number] => 7/642840 [patent_app_country] => US [patent_app_date] => 1991-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3485 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/229/05229367.pdf [firstpage_image] =>[orig_patent_app_number] => 642840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3459327 [patent_doc_number] => 05441933 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-15 [patent_title] => 'Pharmaceutical compositions and dosage forms for the oral administration of calcitonin' [patent_app_type] => 1 [patent_app_number] => 7/640811 [patent_app_country] => US [patent_app_date] => 1991-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2839 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/441/05441933.pdf [firstpage_image] =>[orig_patent_app_number] => 640811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2805358 [patent_doc_number] => 05145951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-08 [patent_title] => 'Peptides retroviral protease inhibitors comprising 2-amino-2-methylpropionic acid' [patent_app_type] => 1 [patent_app_number] => 7/639627 [patent_app_country] => US [patent_app_date] => 1991-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10065 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/145/05145951.pdf [firstpage_image] =>[orig_patent_app_number] => 639627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2801827 [patent_doc_number] => 05140100 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-08-18 [patent_title] => 'Protein that inhibits production of human choriogonadotropin' [patent_app_type] => 1 [patent_app_number] => 7/639249 [patent_app_country] => US [patent_app_date] => 1990-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3852 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/140/05140100.pdf [firstpage_image] =>[orig_patent_app_number] => 639249 [rel_patent_id] =>[rel_patent_doc_number] =>)